PharmAthene, Inc. (PIP)
-NYSE MKT 1.58 0.00(0.00%) 4:01PM EDT
| Prev Close: | 1.58 |
|---|
| Open: | 1.59 |
|---|
| Bid: | 1.39 x 300 |
|---|
| Ask: | 2.09 x 1000 |
|---|
| 1y Target Est: | 7.25 |
|---|
| Beta: | 2.27 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.58 - 1.60 |
|---|
| 52wk Range: | 0.98 - 2.20 |
|---|
| Volume: | 106,700 |
|---|
| Avg Vol (3m): | 350,689 |
|---|
| Market Cap: | 78.15M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.09 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Why PharmAthene Will Win Its Suit With Siga And How Much It Will Collectat Seeking Alpha(Wed 4:40PM EDT)
- PHARMATHENE, INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Mon, Jun 17)
- SIGA Technologies V. PharmAthene: A Comprehensive Analysis Of The Legal Issuesat Seeking Alpha(Mon, Jun 3)
- PharmAthene will proceed with anthrax vaccine testAP(Thu, May 30)
- PharmAthene announces FDA clinical hold on SparVax liftedtheflyonthewall.com(Thu, May 30)
- FDA Lifts Clinical Hold On PharmAthene's SparVax® Anthrax Vaccine ProgramPR Newswire(Thu, May 30)
- PHARMATHENE, INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Thu, May 30)
- SIGA Or Pharmathene: Who Really Won?at Seeking Alpha(Tue, May 28)
- Google Can’t Satisfy EU, JPMorgan Makes a Key Hire, and 3 More Hot Stocksat Wall St. Cheat Sheet(Tue, May 28)
- PHARMATHENE, INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue, May 28)
- SIGA says court reverses 'equitable payment stream' to PharmAtheneat theflyonthewall.com(Sun, May 26)
- Delaware Supreme Court Affirms Lower Court's Ruling That SIGA Technologies Breached Its Contractual Obligation To Negotiate In Good FaithPR Newswire(Sun, May 26)
- July Options Now Available For PharmAthene (PIP)at TheStreet(Mon, May 20)
- PHARMATHENE, INC FinancialsEDGAR Online Financials(Tue, May 14)
- Biodefense: Live By Government Contracts, Die By Government Contractsat Seeking Alpha(Sun, May 12)
Key Statistics
| Forward P/E (1 yr): | 6.58 |
|---|
| P/S (ttm): | 3.06 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.13 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.03 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
PharmAthene, Inc., a biodefense company, engages in the development and commercialization of medical countermeasures against biological and chemical threats in the United States.
View More 
1.35%